financetom
Business
financetom
/
Business
/
DocuSign's Solid Q2 Shows Early Signs of Improving Execution, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DocuSign's Solid Q2 Shows Early Signs of Improving Execution, RBC Says
Sep 5, 2025 6:14 AM

08:37 AM EDT, 09/05/2025 (MT Newswires) -- DocuSign ( DOCU ) delivered better-than-expected fiscal Q2 results with revenue, subscription, billings and operating margins all topping guidance, RBC Capital Markets said in a note Thursday.

Revenue grew 9% year over year to $800.6 million, while non-GAAP EPS was $0.92 above analyst estimates of $0.85, the firm noted.

Billings grew 13%, benefiting from direct sales strength in the company's core eSignature product, the firm said.

Management highlighted growing traction in its Intelligent Agreement Management offering, which RBC said could represent a low double-digit percentage of DocuSign's ( DOCU ) subscription base by fiscal Q4 2026.

"Overall, it was a solid quarter with early signs of improving GTM execution and IAM traction. While valuation appears undemanding, we await more positive data points on IAM before becoming more constructive," the note said.

The company raised its fiscal 2026 guidance across the board, RBC noted.

RBC maintained its sector perform rating on the stock and lifted its price target to $95 from $90.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MediPharm Advances 7% on Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio
MediPharm Advances 7% on Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio
May 26, 2025
09:46 AM EDT, 05/26/2025 (MT Newswires) -- MediPharm Labs ( MEDIF ) on Monday rose 7% after it said it began production on novel cannabis metered dose inhalers for the EU and the United Kingdom, made to global pharmaceutical standards and distributed by Blackpoint, its exclusive sales and distribution partner in those territories. The company expects to launch in Australia,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Finlay Minerals Announces $1 million Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
Finlay Minerals Announces $1 million Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
May 26, 2025
09:17 AM EDT, 05/26/2025 (MT Newswires) -- Finlay Minerals ( FYMNF ) on Monday said it plans to complete a non-brokered private placement for aggregate gross proceeds to the company of up to $1 million. The offering will include the issuance of any combination of flow-through (FT) shares at a price of $0.11 each and non-flow-through (NFT) units at a...
Getchell Gold Increases Private Placement to $4 Million from $3 Million
Getchell Gold Increases Private Placement to $4 Million from $3 Million
May 26, 2025
09:16 AM EDT, 05/26/2025 (MT Newswires) -- Getchell Gold ( GGLDF ) said Monday that it increased the size of its previously announced private placement financing to $4 million from $3 million. The offering comprises units priced at $0.20 apiece. Each unit consists of one share and one-half of a warrant. Each whole warrant is exercisable at $0.30 per share...
Copyright 2023-2026 - www.financetom.com All Rights Reserved